Literature DB >> 15197690

Quality of life after esophagectomy.

Felix G Fernandez1, Bryan F Meyers.   

Abstract

Esophagectomy is associated with high complication rates and consequent mortality. The 5-year survival for esophageal cancer is also discouraging with rates of 6 to 33% after surgery. Nonsurgical series of selected patients have shown similar survival. Therefore, quality of life may be a better assessment of patient outcomes than survival. At present few reports have address quality of life in patients after esophagectomy, particularly in those patients who succumb quickly to recurrent cancer. This article investigates the determinants of quality of life after esophagectomy and reviews the use of quality of life measures in comparative trials. Quality of life measures may become valuable tools in the selection of patients for esophagectomy.

Entities:  

Mesh:

Year:  2004        PMID: 15197690     DOI: 10.1053/j.semtcvs.2004.03.008

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  3 in total

1.  Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus.

Authors:  Lily C Chang; Brant K Oelschlager; Elina Quiroga; Juan D Parra; Michael Mulligan; Doug E Wood; Carlos A Pellegrini
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

2.  An alternative postoperative pathway reduces length of hospitalisation following oesophagectomy.

Authors:  Sandra C Tomaszek; Stephen D Cassivi; Mark S Allen; K Robert Shen; Francis C Nichols; Claude Deschamps; Dennis A Wigle
Journal:  Eur J Cardiothorac Surg       Date:  2009-11-08       Impact factor: 4.191

3.  Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery.

Authors:  M Jacobs; R C Macefield; R G Elbers; K Sitnikova; I J Korfage; E M A Smets; I Henselmans; M I van Berge Henegouwen; J C J M de Haes; J M Blazeby; M A G Sprangers
Journal:  Qual Life Res       Date:  2013-12-03       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.